| P2093 | author name string | Partha S Biswas | |
| P2860 | cites work | CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene | Q24315956 |
| | New insights into innate immune control of systemic candidiasis | Q27002519 |
| | Urinary tract infections: epidemiology, mechanisms of infection and treatment options | Q27022487 |
| | The renal mononuclear phagocytic system | Q27024367 |
| | Epidemiology and risk factors for invasive candidiasis | Q27024911 |
| | The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing | Q27687800 |
| | Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans | Q28508646 |
| | The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney | Q28553220 |
| | IL-23 drives a pathogenic T cell population that induces autoimmune inflammation | Q29547525 |
| | A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 | Q29547855 |
| | Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages | Q29547871 |
| | Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain | Q29614225 |
| | Hidden killers: human fungal infections | Q29617101 |
| | Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice | Q33521257 |
| | Innate IL-17-producing cells: the sentinels of the immune system | Q33608575 |
| | The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection | Q33652449 |
| | Toll-like receptors in kidney disease | Q33960964 |
| | Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis | Q33979319 |
| | Functional specialization of interleukin-17 family members | Q34025860 |
| | An essential role of interleukin-17 receptor signaling in the development of autoimmune glomerulonephritis | Q34066698 |
| | Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice | Q34080154 |
| | Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice | Q34090173 |
| | Urinary tract infections: disease panorama and challenges | Q34136716 |
| | Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice | Q34729932 |
| | Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. | Q34765324 |
| | Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection. | Q34792962 |
| | Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys | Q34892862 |
| | Th17 and natural Treg cell population dynamics in systemic lupus erythematosus | Q34978528 |
| | Interleukin-17A promotes early but attenuates established disease in crescentic glomerulonephritis in mice | Q35167891 |
| | Tetramers reveal IL-17-secreting CD4+ T cells that are specific for U1-70 in lupus and mixed connective tissue disease. | Q35189911 |
| | Recent advances in the IL-17 cytokine family | Q35301277 |
| | Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-α-Dependent, IL-17-Independent Mechanism | Q36116759 |
| | Nonredundant Roles of Interleukin-17A (IL-17A) and IL-22 in Murine Host Defense against Cutaneous and Hematogenous Infection Due to Methicillin-Resistant Staphylococcus aureus. | Q36138054 |
| | The host cytokine responses and protective immunity in oropharyngeal candidiasis | Q36295907 |
| | Innate immunity of surfactant proteins A and D in urinary tract infection with uropathogenic Escherichia coli | Q36373248 |
| | CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy. | Q36383807 |
| | T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. | Q36667205 |
| | Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis | Q36676453 |
| | Dendritic cells in the kidney | Q36931427 |
| | Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy | Q37051768 |
| | Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans | Q37143371 |
| | The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis | Q37181960 |
| | IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen | Q37181998 |
| | Aspects of immune dysfunction in end-stage renal disease | Q37243143 |
| | Complement, roles in renal disease and modulation for therapy. | Q37322699 |
| | The role of IL-23/IL-17 axis in lupus nephritis | Q37397437 |
| | Th1 and Th17 cells induce proliferative glomerulonephritis | Q37477762 |
| | Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease | Q37735334 |
| | Lupus nephritis. How latest insights into its pathogenesis promote novel therapies. | Q38027371 |
| | The immune system and kidney disease: basic concepts and clinical implications. | Q38137749 |
| | Gene polymorphisms of interleukin-17 and interleukin-17 receptor are associated with end-stage kidney disease | Q38456502 |
| | IL-17 Signaling: The Yin and the Yang. | Q39158530 |
| | Plasticity of Th17 Cells in Autoimmune Kidney Diseases | Q39703826 |
| | Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment | Q40083539 |
| | Autoimmune Renal Disease Is Exacerbated by S1P-Receptor-1-Dependent Intestinal Th17 Cell Migration to the Kidney. | Q40449540 |
| | Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members | Q40619563 |
| | IL-17C is required for lethal inflammation during systemic fungal infection | Q40745898 |
| | Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus | Q40953299 |
| | Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. | Q41018056 |
| | Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection | Q41348762 |
| | O-Acetylation of Peptidoglycan Limits Helper T Cell Priming and Permits Staphylococcus aureus Reinfection. | Q41994684 |
| | IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells | Q42243941 |
| | IL-17A production by renal γδ T cells promotes kidney injury in crescentic GN. | Q42321953 |
| | Increased serum interleukin 17 in patients with systemic lupus erythematosus. | Q45327106 |
| | Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice | Q45876568 |
| | IL-17 promotes murine lupus. | Q45942916 |
| | The role of serum IL-17 and IL-6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis | Q46888202 |
| | Exciting developments in the immunology of fungal infections | Q47568389 |
| | Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus | Q48276268 |
| | IL-17F Promotes Tissue Injury in Autoimmune Kidney Diseases | Q49165257 |
| | Interleukin-17 promotes the production of underglycosylated IgA1 in DAKIKI cells | Q49330300 |
| | Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohort. | Q50452713 |
| | Inflammatory Ly6Chigh Monocytes Protect against Candidiasis through IL-15-Driven NK Cell/Neutrophil Activation. | Q50931704 |
| | Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine. | Q51049424 |
| | Unexpected kidney-restricted role for IL-17 receptor signaling in defense against systemic Candida albicans infection. | Q52714508 |
| | SYSTEMIC CANDIDIASIS AND RENAL INVOLVEMENT | Q52763475 |
| | Interleukin-17RA Promotes Humoral Responses and Glomerular Injury in Experimental Rapidly Progressive Glomerulonephritis. | Q52779697 |
| | Interleukin 17 signaling drives Type I Interferon induced proliferative crescentic glomerulonephritis in lupus-prone mice. | Q52903357 |
| | Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients. | Q52944545 |
| | Susceptibility of immunodeficient gene-knockout mice to urinary tract infection. | Q54104339 |
| | Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis | Q58466080 |
| | IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance | Q58855387 |
| | Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis | Q58992083 |
| | Interleukin-17 Stimulates the Release of Pro-inflammatory Cytokines by Blood Monocytes in Patients with IgA Nephropathy | Q73390882 |
| | Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure | Q82923103 |
| | Imbalance of regulatory T cells to Th17 cells in IgA nephropathy | Q83323869 |
| | Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane | Q87292752 |
| | IL-17C/IL-17 Receptor E Signaling in CD4+ T Cells Promotes TH17 Cell-Driven Glomerular Inflammation | Q87887570 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3153-3159 | |
| P577 | publication date | 2018-12-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | IL-17 in Renal Immunity and Autoimmunity | |
| P478 | volume | 201 | |